Form 4: ANI Pharmaceuticals Executive Sells Shares Under 10b5-1 Trading Plan

Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock at $66.54 per share on March 13, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 13, 2024, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold 250 shares of common stock.
• The sale was executed at a price of $66.54 per share.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
• Following the transaction, Meredith Cook directly owns 59,981 shares of ANI Pharmaceuticals.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an executive's stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and are often part of personal financial planning. The use of 10b5-1 trading plans allows insiders to sell shares at predetermined times and prices, avoiding accusations of insider trading.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates